URL: | http://www.drug2gene.com |
Full name: | |
Description: | We have built Drug2Gene, a knowledge base, which combines the compound/drug-gene/protein information from 19 publicly available databases. A key feature is our rigorous unification and standardization process which makes the data truly comparable on a large scale, allowing for the first time effective data mining in such a large knowledge corpus. As of version 3.2, Drug2Gene contains 4,372,290 unified relations between compounds and their targets most of which include reported bioactivity data. We extend this set with putative (i.e. homology-inferred) relations where sufficient sequence homology between proteins suggests they may bind to similar compounds. Drug2Gene provides powerful search functionalities, very flexible export procedures, and a user-friendly web interface. |
Year founded: | 2014 |
Last update: | |
Version: | 3.2 |
Accessibility: |
Manual:
Unaccessible
|
Country/Region: | Germany |
Data type: | |
Data object: | |
Database category: | |
Major species: | |
Keywords: |
University/Institution: | Bayer Pharma |
Address: | Bayer Pharma AG, Müllerstr 178, 13342 Berlin, Germany |
City: | |
Province/State: | |
Country/Region: | Germany |
Contact name (PI/Team): | Weiss B |
Contact email (PI/Helpdesk): | bertram.weiss@bayer.com. |
Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network. [PMID: 24618344]
BACKGROUND: Information about drug-target relations is at the heart of drug discovery. There are now dozens of databases providing drug-target interaction data with varying scope, and focus. Therefore, and due to the large chemical space, the overlap of the different data sets is surprisingly small. As searching through these sources manually is cumbersome, time-consuming and error-prone, integrating all the data is highly desirable. Despite a few attempts, integration has been hampered by the diversity of descriptions of compounds, and by the fact that the reported activity values, coming from different data sets, are not always directly comparable due to usage of different metrics or data formats. |